The U.S. House Judiciary Committee voted Thursday to approve a fourth bill aimed at tackling high drug prices, approving a measure that would make it easier for biosimilar drugs, cheaper versions of expensive biotech drugs, to come to market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,